Skip to content

endomina system

by Endo Tools Therapeutics

endomina system is a Class II device made by Endo Tools Therapeutics, cleared under FDA 510(k) K211309 on 7 Dec 2021 and listed in FDA GUDID since 19 Jul 2022 (UDI-DI 05425029282070), active as of 1 Jun 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 1 Jun 2026

Documents

510(k) K211309

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 1 Jun 2026.

Regulatory status

as of registry sync 1 Jun 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05425029282070 UDI-DI Date19 Jul 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK211309 Date7 Dec 2021DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K211309 decided 7 Dec 2021 Active
  • FDA GUDID UDI-DI 05425029282070 listed 19 Jul 2022 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K211309
  2. Listed FDA GUDID 05425029282070

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Generic name
Endoscopic overtube, single-use
Model / reference
endomina system
Primary DI / UDI-DI
05425029282070
510(k) Number
FDA product code
OCW
GMDN term
Endoscopic overtube, single-use
Device class
Class II
Regulation number
876.1500
GUDID distribution status
In Commercial Distribution
MRI safety
MR Safe

Similar devices in this category

Other devices filed under Endoscopic overtube, single-use.

Other devices from Endo Tools Therapeutics

  • endomina EZFuse suture

    Class II
  • endomina EZFuse system

    Class II
  • Tapes

    Class II
  • endomina platform

    Class II

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
Other properties (11, all answered No)